| Q3 2017 |
38 |
$39.2M |
+$22M |
-$21.6M |
+$450K |
NEE, CME, ICD, AEP, SAVE
|
13F-HR |
11/14/2017, 09:23 AM |
| Q2 2017 |
32 |
$38M |
+$20.1M |
-$51.6M |
-$31.5M |
ICD, NBL, NEE, LNG, DAL
|
13F-HR |
8/14/2017, 06:30 AM |
| Q1 2017 |
29 |
$73.1M |
+$54.6M |
-$33.5M |
+$21.2M |
CVX, XEC, ICD, WPX, NEE
|
13F-HR |
5/15/2017, 08:00 AM |
| Q4 2016 |
24 |
$52.6M |
+$44M |
-$27.7M |
+$16.4M |
SM, CWEI, ICD, CLR, KMI
|
13F-HR |
2/14/2017, 08:04 AM |
| Q3 2016 |
15 |
$35.1M |
+$35.1M |
$0 |
+$35.1M |
RRC, HES, ICD, SYRG, PDCE
|
13F-HR |
11/14/2016, 07:25 AM |
| Q2 2016 |
0 |
$0 |
$0 |
-$137M |
-$137M |
|
13F-HR |
8/15/2016, 07:22 AM |
| Q1 2016 |
68 |
$137M |
+$88.3M |
-$245M |
-$157M |
HUBB, GRA, MSM, ROP, TXT
|
13F-HR |
5/16/2016, 09:26 AM |
| Q4 2015 |
93 |
$299M |
+$220M |
-$271M |
-$51.1M |
KEY, CSRA, SIVB, RHI, VOYA
|
13F-HR |
2/16/2016, 08:17 AM |
| Q3 2015 |
120 |
$350M |
+$218M |
-$360M |
-$142M |
WSO, EME, VC, WTM, CPRT
|
13F-HR |
11/16/2015, 08:59 AM |
| Q2 2015 |
115 |
$511M |
+$389M |
-$204M |
+$185M |
CAT, RITM, HUBB, ITW, TXT
|
13F-HR |
8/14/2015, 08:53 AM |
| Q1 2015 |
132 |
$326M |
+$231M |
-$122M |
+$109M |
HUBB, VOYA, XYL, LMT, AGO
|
13F-HR |
5/15/2015, 09:00 AM |
| Q4 2014 |
105 |
$211M |
$0 |
$0 |
|
AGO, A104PS, GOOG, NRF, SAVE
|
13F-HR |
2/17/2015, 09:02 AM |